Annelies Verbon Selected Research

Annelies Verbon Research Topics

Disease

32	Infections 08/2023 - 08/2002
11	Mycetoma 05/2024 - 01/2020
9	HIV Infections (HIV Infection) 10/2023 - 04/2002
6	Acquired Immunodeficiency Syndrome (AIDS) 11/2022 - 04/2007
5	Urinary Tract Infections (Urinary Tract Infection) 01/2020 - 10/2007
5	Legionnaires' Disease (Legionnaire's Disease) 01/2018 - 08/2002
5	Sepsis (Septicemia) 10/2013 - 07/2009
4	Tuberculosis (Tuberculoses) 01/2017 - 01/2002
4	Pneumonia (Pneumonitis) 12/2004 - 08/2002
3	COVID-19 11/2022 - 01/2020
3	Fibrosis (Cirrhosis) 01/2022 - 01/2019
3	Inflammation (Inflammations) 01/2020 - 10/2019
3	Neutropenia 02/2016 - 01/2014
3	Abscess 01/2014 - 01/2013
3	Endotoxemia 07/2003 - 04/2002
2	Viremia 10/2023 - 01/2019
2	Malaria 01/2020 - 12/2016
2	Communicable Diseases (Infectious Diseases) 11/2019 - 01/2019
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 04/2015
2	Aspergillosis 09/2018 - 07/2015
2	Kaposi Sarcoma (Kaposi's Sarcoma) 11/2016 - 11/2013
2	Dyslipidemias (Dyslipidemia) 04/2015 - 01/2014
2	Diverticulitis 01/2013 - 01/2013
1	Bacterial Pneumonia 11/2022
1	Hyperthermia 12/2021
1	Mycoses (Diseases, Fungus) 01/2021
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2020
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2020
1	Acute Lung Injury 01/2020
1	Rare Diseases (Rare Disease) 01/2020
1	Invasive Fungal Infections 01/2020
1	Meningoencephalitis 01/2020
1	Persistent Infection 01/2019
1	Graft vs Host Disease (Graft-Versus-Host Disease) 09/2018
1	Peritonitis 05/2018

Drug/Important Bio-Agent (IBA)

18	Anti-Bacterial Agents (Antibiotics)IBA 12/2022 - 01/2011
5	CytokinesIBA 01/2020 - 08/2002
4	Itraconazole (Sporanox)FDA LinkGeneric 10/2023 - 01/2020
4	Biomarkers (Surrogate Marker)IBA 10/2023 - 07/2009
4	Antifungal AgentsIBA 06/2022 - 01/2020
4	Inosine TriphosphataseIBA 01/2018 - 01/2012
3	ER 30346 (ravuconazole)IBA 12/2022 - 01/2022
3	Antiviral Agents (Antivirals)IBA 01/2022 - 01/2019
3	AntigensIBA 11/2019 - 12/2002
2	AzolesIBA 10/2023 - 09/2018
2	GlucansIBA 10/2023 - 04/2023
2	NucleosidesIBA 10/2023 - 01/2014
2	Reverse Transcriptase InhibitorsIBA 10/2023 - 01/2014
2	Amphotericin B (Amphotericin)FDA LinkGeneric 08/2023 - 01/2002
2	Melanins (Melanin)IBA 02/2022 - 01/2021
2	olorofimIBA 01/2022 - 01/2020
2	CarbamatesIBA 01/2022 - 01/2022
2	benzimidazoleIBA 01/2022 - 01/2022
2	Viral RNAIBA 11/2021 - 01/2021
2	Interleukin-12 (IL 12)IBA 12/2019 - 08/2012
2	dolutegravirIBA 10/2019 - 12/2017
2	Proteins (Proteins, Gene)FDA Link 01/2012 - 11/2005
2	Toll-Like Receptor 4IBA 02/2005 - 08/2002
2	Toll-Like Receptors (Toll-Like Receptor)IBA 12/2004 - 11/2003
2	LipopolysaccharidesIBA 08/2002 - 04/2002
1	resazurinIBA 05/2024
1	APX001AIBA 11/2023
1	IntegrasesIBA 10/2023
1	Protease Inhibitors (Protease Inhibitor)IBA 10/2023
1	polyglucosanIBA 04/2023
1	Indicators and Reagents (Reagents)IBA 11/2022
1	luliconazoleIBA 06/2022
1	latoconazole (lanoconazole)IBA 06/2022
1	Terbinafine (Lamisil)FDA LinkGeneric 01/2022
1	FenbendazoleIBA 01/2022
1	COVID-19 VaccinesIBA 01/2022
1	Illicit Drugs (Recreational Drugs)IBA 01/2022
1	Neutralizing AntibodiesIBA 11/2021
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2020
1	Valsartan (Vals)FDA Link 01/2020
1	1- acetyl- 1,2,3,3a,8,8a- hexahydro- 8a- hydroxy- 5- methoxypyrrolo(2,3- b)indole (CHMI)IBA 01/2020
1	Angiotensin IIIBA 01/2020
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2020
1	Alanine Transaminase (SGPT)IBA 11/2019
1	AerosolsIBA 11/2019
1	LipidsIBA 10/2019
1	abacavir (Ziagen)FDA Link 01/2019
1	RNA (Ribonucleic Acid)IBA 01/2019
1	InterferonsIBA 01/2019
1	Biogenic Amines (Biogenic Amine)IBA 11/2018
1	Tryptophan (L-Tryptophan)FDA Link 11/2018
1	Triglycerides (Triacylglycerol)IBA 11/2018
1	NitrogenIBA 11/2018
1	Phospholipids (Phosphatides)FDA LinkGeneric 11/2018
1	SphingomyelinsIBA 11/2018
1	QuinolonesIBA 05/2018
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2018
1	ametantrone (HAQ)IBA 01/2018
1	Bacterial DNAIBA 01/2018

Therapy/Procedure

20	Therapeutics 10/2023 - 12/2002
10	Highly Active Antiretroviral Therapy (HAART) 01/2022 - 07/2009
3	Art Therapy 11/2022 - 01/2020
1	Continuity of Patient Care 11/2022
1	Treatment Delay 01/2019
1	Antibiotic Prophylaxis 05/2018